Dynamic inflammatory biomarkers as prognostic indicators in advanced breast cancer patients receiving PD-1 inhibitors
Therapeutic Advances in Medical Oncology
Published online on May 14, 2026
Abstract
Therapeutic Advances in Medical Oncology, Volume 18, January-December 2026.
Background:While programmed cell death protein 1 (PD-1) inhibitors benefit breast cancer patients, simple predictors of their efficacy are lacking.Objectives:This study aimed to evaluate inflammatory markers as prognostic indicators for advanced breast ...
Background:While programmed cell death protein 1 (PD-1) inhibitors benefit breast cancer patients, simple predictors of their efficacy are lacking.Objectives:This study aimed to evaluate inflammatory markers as prognostic indicators for advanced breast ...